Refine Your Search

  • Solutions

  • Therapeutic Areas

  • Resource Type

Managing Pre-clinical Study Data as a Strategic Asset

In this webinar, David Lowis, D. Phil. of Certara, makes the case for adopting a solution that allows immediate access, visualization and analysis of pre-clinical data for optimized decision making, while leveraging the FDA mandated CDISC-SEND data standard. Joining Dr. Lowis will be Stuart Horowitz, PhD, President of Institutional Services at WIRB-Copernicus Group. Dr. Horowitz […]

Speaker(s): David Lowis
Solution: Scientific Informatics
More Info

Phoenix WinNonlin: A State of the Art Software Tool for Pre-clinical PK and TK Analysis

Are you currently using Excel for PK/TK analysis? Phoenix WinNonlin streamlines analyses and generates all of the output needed for non-compartmental analysis, TK, PK and PK/PD studies from within a single, validatable environment. Highlights of this webinar included: Sophisticated plotting of PK data Calculation of key PK parameters Cmax, Tmax, AUClast, AUCinf, Clearance Statistical summary […]

Speaker(s): Christopher Mehl
Solution: Model-informed Drug Development, PK/PD Modeling & Simulation
More Info

Introduction to Population PK/PD Analysis Using Phoenix NLME

Phoenix NLME provides sophisticated algorithms and powerful and flexible data processing and modeling tools for population PK/PD analyses with an intuitive graphical user interface. The Phoenix system can be customized for any type of modeler from beginners to experts. Phoenix NLME is easy to learn as it has built-in PK/PD libraries that can be used […]

Speaker(s): Serge Guzy
Solution: Model-informed Drug Development, PK/PD Modeling & Simulation
More Info

Powering Pediatric Studies to Meet FDA Criteria

Effective medications are a mainstay of modern pediatric medicine. Yet, ethical concerns about conducting clinical trials in pediatric patients are a major challenge in pediatric drug development. Learn how Dr. Samer Mouksassi and his team at Certara Strategic Consulting have overcome these challenges through the use of pharmacometrics.

Speaker(s): Samer Mouksassi
Solution: Clinical Trials Simulation, Model-informed Drug Development, PK/PD Modeling & Simulation
Therapeutic Area: Pediatrics
More Info